ZA888391B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA888391B ZA888391B ZA888391A ZA888391A ZA888391B ZA 888391 B ZA888391 B ZA 888391B ZA 888391 A ZA888391 A ZA 888391A ZA 888391 A ZA888391 A ZA 888391A ZA 888391 B ZA888391 B ZA 888391B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT22647/87A IT1223132B (en) | 1987-11-13 | 1987-11-13 | PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA888391B true ZA888391B (en) | 1989-08-30 |
Family
ID=11198823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA888391A ZA888391B (en) | 1987-11-13 | 1988-11-09 | Pharmaceutical compositions |
Country Status (11)
Country | Link |
---|---|
CN (1) | CN1027225C (en) |
BE (1) | BE1002333A3 (en) |
CA (1) | CA1329764C (en) |
FR (1) | FR2623090B1 (en) |
IL (1) | IL88316A (en) |
IT (1) | IT1223132B (en) |
MY (1) | MY104345A (en) |
NZ (1) | NZ226812A (en) |
PT (1) | PT88978B (en) |
ZA (1) | ZA888391B (en) |
ZW (1) | ZW14688A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT8920486A0 (en) * | 1989-05-12 | 1989-05-12 | Isf Spa | PHARMACEUTICAL COMPOSITIONS. |
EP0432431B1 (en) * | 1989-11-16 | 1993-06-16 | PHIDEA S.p.A. | Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
IT1238072B (en) * | 1990-01-19 | 1993-07-03 | Sclavo Spa | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ORAL ADMINISTRATION OF CALCITONIN |
IT1248725B (en) * | 1990-06-12 | 1995-01-26 | Sclavo Spa | PHARMACEUTICAL COMPOSITION POWDER FOR NASAL ADMINISTRATION CONTAINING ESSENTIAL CALCITONIN AND A WATER SOLUBLE EXCIPIENT |
CN101721376B (en) * | 2009-12-30 | 2011-06-01 | 上海交通大学 | Calcitonin sustained-release microsphere composition and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5927978A (en) * | 1982-08-09 | 1984-02-14 | Terumo Corp | Indometacin-containing adhesive tape |
JPS61267528A (en) * | 1984-11-26 | 1986-11-27 | Yamanouchi Pharmaceut Co Ltd | Transnasal calcitonin agent containing absorbefacient |
CA1335076C (en) * | 1987-04-01 | 1995-04-04 | Hanna R. Kowarski | Pharmaceutical composition and method for intranasal administration |
-
1987
- 1987-11-13 IT IT22647/87A patent/IT1223132B/en active Protection Beyond IP Right Term
-
1988
- 1988-10-31 MY MYPI88001240A patent/MY104345A/en unknown
- 1988-11-02 NZ NZ226812A patent/NZ226812A/en unknown
- 1988-11-02 CA CA000581928A patent/CA1329764C/en not_active Expired - Fee Related
- 1988-11-04 ZW ZW146/88A patent/ZW14688A1/en unknown
- 1988-11-07 IL IL88316A patent/IL88316A/en not_active IP Right Cessation
- 1988-11-08 FR FR888814576A patent/FR2623090B1/en not_active Expired - Fee Related
- 1988-11-09 ZA ZA888391A patent/ZA888391B/en unknown
- 1988-11-10 PT PT88978A patent/PT88978B/en not_active IP Right Cessation
- 1988-11-10 BE BE8801287A patent/BE1002333A3/en not_active IP Right Cessation
- 1988-11-12 CN CN88107895A patent/CN1027225C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA1329764C (en) | 1994-05-24 |
CN1027225C (en) | 1995-01-04 |
BE1002333A3 (en) | 1990-12-18 |
PT88978A (en) | 1988-12-01 |
FR2623090A1 (en) | 1989-05-19 |
NZ226812A (en) | 1990-06-26 |
IL88316A (en) | 1993-04-04 |
CN1033568A (en) | 1989-07-05 |
MY104345A (en) | 1994-03-31 |
IT1223132B (en) | 1990-09-12 |
ZW14688A1 (en) | 1989-08-02 |
FR2623090B1 (en) | 1994-09-09 |
PT88978B (en) | 1993-04-30 |
IT8722647A0 (en) | 1987-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3002410T3 (en) | Pharmaceutical compositions | |
GB2204792B (en) | Pharmaceutical composition | |
ZA883212B (en) | Pharmaceutical compositions | |
GB8826321D0 (en) | Pharmaceutical compositions | |
EG18652A (en) | Pharmaceutical compositions | |
GB8804697D0 (en) | Pharmaceutical compositions | |
GB8810716D0 (en) | Pharmaceutical compositions | |
GB8713091D0 (en) | Pharmaceutical compositions | |
ZA888391B (en) | Pharmaceutical compositions | |
ZA882861B (en) | Pharmaceutical compositions | |
GB8827838D0 (en) | Pharmaceutical compositions | |
GB8716380D0 (en) | Pharmaceutical compositions | |
GB8700811D0 (en) | Pharmaceutical compositions | |
GB8716784D0 (en) | Pharmaceutical compositions | |
GB8716783D0 (en) | Pharmaceutical compositions | |
GB8716434D0 (en) | Pharmaceutical compositions | |
GB8723187D0 (en) | Pharmaceutical compositions | |
GB8713349D0 (en) | Pharmaceutical compositions | |
GR871629B (en) | Pharmaceutical compositions | |
GB8711680D0 (en) | Pharmaceutical compositions | |
GB8710966D0 (en) | Pharmaceutical compositions | |
IE870950L (en) | Pharmaceutical compositions | |
GB8708766D0 (en) | Pharmaceutical compositions | |
GB8708765D0 (en) | Pharmaceutical compositions | |
GB8706258D0 (en) | Pharmaceutical compositions |